Market Cap : 229.49 B | Enterprise Value : 251.05 B | PE Ratio : 13.86 | PB Ratio : 5.32 |
---|
NYSE:MRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Merck's cash to debt ratio for the quarter that ended in Jun. 2022 was 0.32.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Merck couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2022.
The historical rank and industry rank for Merck's Cash-to-Debt or its related term are showing as below:
During the past 13 years, Merck's highest Cash to Debt Ratio was 6.12. The lowest was 0.22. And the median was 0.64.
MRK's Cash-to-Debt is ranked worse thanThe historical data trend for Merck's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Merck's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Merck's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Merck's Cash-to-Debt falls into.
This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Merck's Cash to Debt Ratio for the fiscal year that ended in Dec. 2021 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 8096 | / | (2412 | + | 30690) | |
= | 0.24 |
Merck's Cash to Debt Ratio for the quarter that ended in Jun. 2022 is calculated as:
Cash to Debt Ratio | = | Cash, Cash Equivalents, Marketable Securities | / | Total Debt | ||
= | Cash, Cash Equivalents, Marketable Securities | / | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | |
= | 10128 | / | (2979 | + | 28684) | |
= | 0.32 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Thank you for viewing the detailed overview of Merck's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Baker Douglas M Jr | director | 370 WBASHA ST NORTH ST PAUL MN 55102 |
Oosthuizen Johannes Jacobus | officer: SVP, U.S. Market | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Garay Arpa | officer: SVP Human Health Global Mktg. | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Downing Cristal N | officer: Chief Comm. & Public Afrs Ofcr | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Klobuchar Michael A | officer: EVP - Chief Strategy Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Lecointe-cephas Lisa | officer: SVP Chief Ethics & Com Officer | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Litchfield Caroline | officer: EVP & CFO | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Mayo Stephen | director | 2000 GALLOPING HILL RD KENILWORTH NJ 07033 |
Li Dean Y | officer: Executive VP & President, MRL | 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Williams David Michael | officer: EVP,Chief Info&Digital Officer | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Lavizzo-mourey Risa J | director | GENERAL ELECTRIC COMPANY 5 NECCO STREET BOSTON MA 02210 |
Seidman Christine E | director | MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 |
Warden Kathy J | director | 2980 FAIRVIEW PARK DRIVE FALLS CHURCH VA 22042 |
Craig Pamela | director | C/O ACCENTURE 161 N CLARK STREET CHICAGO IL 60601 |
Brun Leslie A | director | 435 DEVON PARK DRIVE 700 BUILDING WAYNE PA 19087 |
Other Sources
By Zacks 2022-03-28
By Zacks 2022-04-04
By Zacks 2022-03-22
By tipranks.com 2022-03-28
By Zacks 2022-04-04
By Zacks 2022-03-29
By Zacks 2022-03-29
By Zacks 2022-03-28
By Zacks 2022-03-29
By Zacks 2022-03-28
By tipranks.com 2022-03-22
By Zacks 2022-03-21
By Zacks 2022-03-17
By Zacks 2022-03-23